Stem Cells, Genome Editing, and the Path to Translational Medicine

Stem Cells, Genome Editing, and the Path to Translational Medicine

The derivation of human embryonic stem cells (hESCs) and the stunning discovery that somatic cells can be reprogrammed into human induced pluripotent stem cells (hiPSCs) holds the promise to revolutionize biomedical research and regenerative medicine. In this Review, we focus on disorders of the cen...

Full description

Bibliographic Details
Main Authors:	Soldner, Frank (Author), Jaenisch, Rudolf (Author)
Other Authors:	Massachusetts Institute of Technology. Department of Biology (Contributor)
Format:	Article
Language:	English
Published:	Elsevier BV, 2020-06-24T15:37:24Z.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Induced Pluripotent Stem Cells Meet Genome Editing
by: Hockemeyer, Dirk, et al.
Published: (2018)

Genome‐edited adult stem cells: Next‐generation advanced therapy medicinal products
by: Karim Benabdellah, et al.
Published: (2020-06-01)

Stem Cell Research: Promise and Progress
by: Rudolf Jaenisch, MD
Published: (2015-06-01)

A brief review of genome editing technology for generating animal models
by: Haoyi WANG, Sen WU, Mario R. CAPECCHI, Rudolf JAENISCH
Published: (2020-06-01)

Nuclear Cloning and Direct Reprogramming: The Long and the Short Path to Stockholm
by: Jaenisch, Rudolf
Published: (2014)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016-01-01)

Therapy Development by Genome Editing of Hematopoietic Stem Cells
by: Lola Koniali, et al.
Published: (2021-06-01)

Genome Editing in Medicine: Tools and Challenges
by: Gunda Petraitytė, et al.
Published: (2021-08-01)

Genome Editing Technologies: Defining a Path to Clinic
by: Corrigan-Curay, Jacqueline, et al.
Published: (2017)

Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells
by: Guenther, Matthew G., et al.
Published: (2015)

Perinatal Stem Cells - Biology, Manufacturing and Translational Medicine
by: Manuela Monti
Published: (2021-06-01)

Stem cells and regenerative medicine: The time is right for translation
by: Prof. Gang Li, MBBS, DPhil (Oxon)
Published: (2017-04-01)

Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
by: Samuele Ferrari, et al.
Published: (2021-03-01)

The legal aspect of genome editing in human medicine
by: Sovilj Ranko
Published: (2020-01-01)

Tracing Dynamic Changes of DNA Methylation at Single-Cell Resolution
by: Stelzer, Yonatan, et al.
Published: (2017)

Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
by: Saha, Krishanu, et al.
Published: (2015)

Editing DNA Methylation in the Mammalian Genome
by: Liu, X. Shawn, et al.
Published: (2018)

Methods and applications of CRISPR/Cas system for genome editing in stem cells
by: Guang Yang, et al.
Published: (2019-12-01)

STEM CELLS Translational Medicine: A Decade of Evolution to a Vibrant Stem Cell and Regenerative Medicine Global Community
by: Anthony Atala
Published: (2021-02-01)

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
by: Stamatis Papathanasiou, et al.
Published: (2021-10-01)

Genome Editing Redefines Precision Medicine in the Cardiovascular Field
by: Elda Dzilic, et al.
Published: (2018-01-01)

Journal of Translational Medicine advances in Translational Genomics and Genetics Era
by: Wei Liu
Published: (2019-04-01)

CNS disease models with human pluripotent stem cells in the CRISPR age
by: Muffat, Julien, et al.
Published: (2018)

Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
by: Kasturi Sengupta, et al.
Published: (2020-12-01)

Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
by: Chia-Yu Chang, et al.
Published: (2018-03-01)

When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells
by: Fuquan Chen, et al.
Published: (2017-01-01)

Genome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases.
by: Danielle A Fanslow, et al.
Published: (2014-01-01)

Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine
by: Andrea Ballini, et al.
Published: (2017-01-01)

Human embryonic stem cells with biological and epigenetic to those of mouse ESCs
by: Jaenisch, Rudolf, et al.
Published: (2011)

Translating genomic medicine to the clinic: challenges and opportunities
by: Huan Zhang, et al.
Published: (2019-02-01)

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
by: Natalia Gomez-Ospina, et al.
Published: (2019-09-01)

Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection
by: Benjamin Steyer, et al.
Published: (2018-02-01)

Genome editing of human pluripotent stem cells to generate human cellular disease models
by: Kiran Musunuru
Published: (2013-07-01)

Translational Research and Therapeutic Applications of Stem Cell Transplantation in Periodontal Regenerative Medicine
by: Hong Lu, et al.
Published: (2013-02-01)

Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine
by: Sepideh Nikfarjam, et al.
Published: (2020-11-01)

Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine 2018
by: Andrea Ballini, et al.
Published: (2018-01-01)

The role of editing in translating
by: N S Zvereva
Published: (2009-06-01)

In vitro modelling of recessive dystrophic epidermolysis bullosa (RDEB) using stem cells and genome editing
by: Marx, Jennifer
Published: (2019)

Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells
by: Stephan Riesenberg, et al.
Published: (2018-06-01)

Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools
by: Adrian Kee Keong Teo, et al.
Published: (2015-09-01)